Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
665
datasets available to search
ShareScore release 0.9.0
Dataset results
665 results for “Exons”
Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT04858958. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
ClinicalTrials.gov study NCT01541709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
ClinicalTrials.gov study NCT01772043. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ClinicalTrials.gov study NCT06031688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
ClinicalTrials.gov study NCT06247826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
ClinicalTrials.gov study NCT07038824. IPD Sharing: NO. Countries: 5. Publications: 0.
A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment
ClinicalTrials.gov study NCT06079736. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment
ClinicalTrials.gov study NCT06772233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05267288. IPD Sharing: NO. Countries: 1. Publications: 0.
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants
ClinicalTrials.gov study NCT04370860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
ClinicalTrials.gov study NCT06087263. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
ClinicalTrials.gov study NCT05967689. IPD Sharing: NO. Countries: 12. Publications: 0.
A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.
ClinicalTrials.gov study NCT06142617. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States
ClinicalTrials.gov study NCT06161051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
ClinicalTrials.gov study NCT04004065. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
ClinicalTrials.gov study NCT05524883. IPD Sharing: NO. Countries: 9. Publications: 0.
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06706713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation
ClinicalTrials.gov study NCT05435846. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
ClinicalTrials.gov study NCT01714908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.
ClinicalTrials.gov study NCT07274761. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.